author-photo

Yukari Shirasugi

Tokai University

48

Papers

591

Citations

Citation Trend

Filter By

Papers (37) Sort By

Journal Conference Others

Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell lymphoma.

2021 Cancer Science
Show All
- Source
- Cite
- Save
Citations (3)
The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.

2020 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (3)
To what extent does the EQ-5D-3L correlate with the FACT-H&N of patients with oral cancer during the perioperative period?

2019 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Phase I study of tirabrutinib ( ONO ‐4059/ GS ‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan

2019 Cancer Science
Show All
- Source
- Cite
- Save
Citations (24)
THE RELATIONSHIP BETWEEN THE PRETREATMENT PNH CLONE SIZE AND CLINICAL COURSE IN PATIENTS WITH BONE MARROW FAILURE SYNDROMES: INTERIM ANALYSIS OF JAPANESE MULTICENTER PROSPECTIVE STUDY: PS1115

2019
Show All
- Source
- Cite
- Save
Citations (0)
A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia

2018 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (3)
Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure

2018 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (8)
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

2018 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (62)
Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell NHL

2018
- Yukari Shirasugi
Show All
- Source
- Cite
- Save
Citations (0)
NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib

2017 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (13)